Parexel in collaboration with Innoplexus have launched the COVID-19 Clearinghouse, an online resource for patients, researchers and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials and current news related to COVID-19.
Parexel and Innoplexus created the COVID-19 Clearinghouse as a single, virtual location to access current and credibly sourced COVID-19 information. While the clearinghouse is accessible to anyone seeking information related to COVID-19, researchers will benefit from a consolidated repository of information.
“Parexel is harnessing the power of data to help our industry solve the toughest of challenges during this unprecedented time,” said Michelle Hoiseth, Chief Data Officer for Parexel. “Leveraging Innoplexus’ technology, our Scientific Data organization has automated the collection and organization of COVID data points pulled from thousands of structured and unstructured datasets, publications, clinical trials and news sources that are deemed credible and reliable from a scientific perspective. Our objective is to help researchers, sponsors and patients overcome barriers to accessing accurate data about the pandemic. We are focused on informing important decisions on the path to a solution for this global health crisis.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
Provided as a service to the industry, the COVID-19 Clearinghouse incorporates information from 100+ different geographies providing access to 22,853 datasets, 65,602 publications, 5,173 clinical trials and the latest 229,738 relevant news articles.
"Innoplexus is transforming drug discovery and development with its largest AI@scale platform,” said Dr. Gunjan Bhardwaj, Founder and Chief Executive Officer of Innoplexus. “Partnering with Parexel to enable the fight against COVID shows our commitment yet again to use our resources effectively and speedily to win against this global pandemic."